1 ression of AR-regulated genes in response to androgen antagonists.

2 gand binding domain, where hormones and anti-androgen antagonists act, but still activates AR signali

3 srupt the microtubule assembly and act as an androgen antagonist, and varying the second axial positi

4 fic antigen gene promoter in response to the androgen antagonist bicalutamide, suggesting that Ebp1 d

5                 In vitro studies showed that androgen antagonist, bicalutamide, transiently elevated

6 ld-type male mice treated with flutamide, an androgen antagonist, exhibit reduced renal CYP2J5 levels

7 cement (n=7/group) were pre-treated with the androgen antagonist flutamide (15 mg/kg sc) or ethanol (

8 Finally, treatment of pregnant rats with the androgen antagonist flutamide eliminates the gender diff

9 was blocked by cotreatment with the specific androgen antagonist hydroxyflutamide.

10      A short synthesis of medicinally active androgen antagonist illustrates the utility of the prese

11 at 13, to discriminate between androgen- and androgen antagonist-induced AR conformations.

12 e inhibitor; FemeraTM); (e) Flutamide + ATD (androgen antagonist plus steroidal aromatase inhibitor);

13 inize" them and males received flutamide, an androgen antagonist, to "feminize" them.

14  samples, and di(2-ethylhexyl) phthalate, an androgen antagonist, was detected in one-third of the sa